AscellaHealth Recognized by The Financial Times for Three Consecutive Years as One of “Americas' Fastest Growing Companies”
The data was collected via desk research in official sources like publicly available earning presentations, investor relations, websites and annual reports.
AscellaHealth, a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance quality of life for patients with complex, chronic conditions, today announces that for the third consecutive year it has been recognized as one of “Americas' Fastest Growing Companies,” by The Financial Times. With a four-year growth rate of 623% and an expanding portfolio of custom solutions for all industry stakeholders, AscellaHealth continues its global expansion throughout the Americas and EU, with plans underway to bring its end-to-end solutions to patients throughout Asia and UAE.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240409694714/en/
(Graphic: Business Wire)
“The Financial Times is truly a source of truth for industry stakeholders worldwide and this continued recognition as one of the 500 fastest-growing companies throughout North and South America is testimony to the strength of our innovative solutions that accelerate patient access to specialized therapies,” says Dea Belazi, CEO, AscellaHealth. “As we expand our global footprint, an even greater number of life science manufacturers will rely upon AscellaHealth as a trusted, single-source specialty pharmaceutical partner with tech-enabled support from pre-commercialization through launch, market access, exclusive distribution and beyond.”
The Americas' Fastest Growing Companies 2024 ranking lists the top 500 companies in the Americas that have achieved the highest compound annual growth in revenues between 2019 and 2022. The data was collected via desk research in official sources like publicly available earning presentations, investor relations, websites and annual reports.
“Every day our team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma,” says Belazi. “We partner with life sciences manufacturers around the world, enabling them to successfully commercialize therapies for complex, chronic conditions. Concurrently, we are raising the bar and resetting standards for managing pharmacy costs through our comprehensive suite of services for payers, including government and private insurers.”
About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. Visit www.AscellaHealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409694714/en/